Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Aadi Bioscience Inc AADI

Healthcare Biotechnology
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on developing and commercializing precision therapies for cancers with alterations in the mammalian target of rapamycin (mTOR) pathway, a regulator of cell growth and cancer progression. Its lead drug product, FYARRO, is an mTOR inhibitor indicated for the treatment of adult patients with locally... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AADI)

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

PR Newswire 13 hours ago

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

PR Newswire November 6, 2024

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

PR Newswire October 30, 2024

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

PR Newswire August 20, 2024

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

PR Newswire August 7, 2024

Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update

PR Newswire July 31, 2024

Aadi Bioscience to Participate in the Jefferies Healthcare Conference

PR Newswire May 29, 2024

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

PR Newswire May 23, 2024

Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update

PR Newswire May 8, 2024
View More News ››

Opinion & Analysis (NDAQ:AADI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:AADI)

ZACKS NEW #1 STRONGEST BUY

Better than expected earnings expected and is currently a Zack's STRONG buy. Price target of 40% upside.    READ THE...
yorgosGK - April 16, 2020
View more Bullboard ››

AJA Health and Wellness Inc.

AJA Health and Wellness Inc.

AJA Health and Wellness Inc. is focused on health and wellness solutions. The Company is engaged in operating a telemedicine ...
View More »